Jodi Halpern Discusses CRISPR and Society at 2019 World Economic Forum

The 2019 World Economic Forum convened in Davos, Switzerland to discuss global questions and emerging international issues. Following the recent announcement of the world’s first genome-edited babies, the WEF invited two distinguished speakers to discuss how genome editing may impact the future of humanity.

IGI Investigator Jodi Halpern shared the stage with Victor Dzau, president of the National Academy of Medicine, and Oliver Cann, the World Economic Forum’s head of strategic communications. Watch the 34-min. video below to hear their thoughts on how CRISPR technology may impact society and what types of regulations the international community can devise to responsibly control these outcomes.

Jodi Halpern’s research interests focus on understanding patient consent and understanding. Halpern is working with collaborators to improve the regulatory pathways involved in bringing innovative technologies to the clinic in a cost-effective and timely manner. To learn more about Halpern’s IGI-funded research, please visit her project page.